Oncology tests, women’s health tests, organ health tests, and rare disease tests belong to the focus of Natera, a company specializing in molecular diagnostics and cell-free DNA testing. Key products include Signatera™, Prospera™, and Panorama™.
...
Natera's tests are clinically validated in over 400 peer-reviewed publications, having studied over 3 million patients, aiming to support personalized health care decisions and enhance early disease detection.